Sai Life Sciences Adjusts Evaluation Score Amid Strong Profit Growth and Debt Management

Jun 20 2025 08:17 AM IST
share
Share Via
Sai Life Sciences has recently seen a change in its evaluation score, reflecting shifts in stock performance metrics. The company reported a significant increase in profits and net sales, alongside a strong ability to manage debt, with notable institutional backing indicating investor confidence in its fundamentals.
Sai Life Sciences, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced an adjustment in its evaluation score. This revision reflects a shift in the technical trends observed in the stock's performance metrics.

The company’s current stock price stands at 730.00, slightly lower than the previous close of 738.35. Over the past year, the stock has shown a return of 0.00%, while profits have notably increased by 82%. The company has demonstrated a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.25 times. Additionally, net sales for the latest quarter reached Rs 567.01 crore, marking a growth of 40.8% compared to the previous four-quarter average.

Operating profit has also shown robust growth, with an annual increase of 87.31%. The stock's institutional holdings are significant, currently at 25.62%, indicating a solid backing from investors who typically possess greater analytical resources. This stake has seen an increase of 1.95% from the previous quarter, suggesting a continued interest in the company's fundamentals.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News